iShares Nasdaq Biotechnology Index Fund is an open-end management investment company. The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ. As of Mar 31 2015, the Fund's total assets were $9,494,443,846 and the Fund's investment portfolio was valued at $9,486,288,900. We show 107 historical shares outstanding datapoints in our IBB shares outstanding history coverage, used to compute IBB market cap on those dates.
Understanding the changing numbers of shares outstanding, the changing
share price, and the resulting changing IBB market cap history over the course of time is important for investors
interested in comparing IBB's market cap history versus its peers.
Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies,
and then calculating their respective market caps. Comparing the share price of IBB versus a peer is one thing; comparing
IBB market cap versus a peer is a completely different story.
Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares),
the market cap for a company like IBB can fluctuate over the course of history.
With this page we aim to empower investors researching IBB by allowing them to research the IBB market cap history. |
Free IBB Email Alerts:
Video: The Importance of Market Cap
